Dopamine Hydrochloride Injection
Product Images NDC 51662-1490

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 51662-1490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
This is a product description of dopamine hydrochloride injection in different concentrations and volumes. It comes in bottles of LV solution with varying concentrations ranging from 200 meg/mL to 3200 meg/mL. The available sizes of bottles include 250 mL, 500 mL, and 1000 mL.*
FDA Label Image

Hs (Hs)

Hs (Hs)
This is a list of different packaging options available for a medication with varying strengths depending on the dosage amount per milliliter. The medication is packaged in vials and each carton contains 25 of them. The NDC numbers are provided for each packaging strength.*
FDA Label Image

Serialized Label (Serialized Labeling)

Serialized Label (Serialized Labeling)
This is a prescription drug manufactured by an unnamed company. The recommended dosage is 400mg/10mL, which is available in a single dose vial of 10mL distributed by HF Acquisition Co., LLC in Mukilteo, WA 98275. The provided text does not reveal the drug's name, usage, or side effects.*
FDA Label Image

Structure (Structure)

FDA Label Image

Vial (Vial Label)

Vial (Vial Label)
This is an information on DOPamine Hydrochloride Injection, USP, a medication with NDC 0143-9254-01 for intravenous use, packaged in a 10 mL vial containing 400 mg of dopamine hydrochloride. The medication must be diluted and caution must be exercised in its use. Each mL of this medication contains sodium metabisulfite 9 mg added as a stabilizer, citric acid anhydrous 10 mg, and sodium citrate dehydrate 5 mg added as a buffer. This medication is sterile and nonpyrogenic. The manufacturer of the medication is Hikma Farmaceutica (Portugal) SA. Lot number and expiry date of the medication are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.